The total number and the integrity of the auditory neurones available for s
timulation govern the benefits that patients can derive from cochlear impla
nts. Although electrical stimulation of the cochlea has been reported to pr
omote auditory neuronal survival; this trophic effect is insufficient to re
generate cie novo fibres. Hence, any agent that can maximize the number of
or regenerate functional auditory neurones would be of great benefit. Sever
al studies have identified various growth factors crucial to the normal dev
elopment of auditory neurones. In addition, in vitro studies have demonstra
ted that several growth factors are important for the maintenance; rescue a
nd repair of adult auditory neurones. In vivo studies confirm the in vitro
findings, reporting that specific growth factors are able to support audito
ry neuronal survival following injury or trauma, and in lower species growt
h factors have been associated with regenerating auditory neurones. In addi
tion to their trophic actions, several growth factors have also been report
ed to affect ion channels thus the electrical response of neuronal fibres.
Indeed, growth factors have been reported to enhance neuronal excitation an
d to improve the efficacy of synaptic transmission. Taken in concert, these
effects suggest that exogenous growth factors delivered to the cochlea may
improve the transmission of the electrical stimuli from the implanted elec
trode to the auditory pathway. Further studies are warranted to investigate
how the adjunct delivery of growth factors with the cochlear implant may c
onstitute a better treatment for hearing-impaired individuals.